Comparing Active Versus Passive Aspiration in Therapeutic Thoracentesis: Efficacy, Procedure Time, and Patient Safety
Thoracentesis
2 other identifiers
interventional
60
1 country
1
Brief Summary
This single-blind randomized controlled trial (RCT) aims to compare the efficacy and safety of active manual aspiration versus passive gravity drainage during therapeutic thoracentesis for large symptomatic pleural effusions. A total of 60 eligible patients will be randomized into two equal groups. The active aspiration group will undergo fluid removal using manual syringe suction, while the passive aspiration group will undergo drainage via gravity. The primary outcomes of the study are the total procedure time and the volume of pleural fluid aspirated. Secondary outcomes include patient-reported pain (measured on a Numeric Rating Scale), patient-reported dyspnea (measured by the mMRC scale), the incidence of procedure-related cough, and the reason for procedure termination. The goal of this study is to determine which technique offers a better balance of efficiency and patient comfort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
September 7, 2025
CompletedFirst Posted
Study publicly available on registry
September 22, 2025
CompletedSeptember 22, 2025
September 1, 2025
2 years
September 7, 2025
September 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Volume of Fluid Aspirated
The total volume of pleural fluid successfully removed during the procedure, measured in milliliters (ml).
Immediately upon procedure completion (at the time of needle removal) and fluid extraction.
Procedure Time for Therapeutic Thoracentesis
The total duration of the thoracentesis procedure, measured in minutes, from the initial needle insertion until the procedure was terminated. Termination occurred when no more fluid could be drained, the target volume was reached, or due to patient complications like cough or discomfort.
Immediately upon procedure completion (at the time of needle removal) and fluid extraction.
Secondary Outcomes (3)
Patient-Reported Pain
Immediately upon procedure completion (at the time of needle removal) and fluid extraction.
Patient-Reported Dyspnea
Immediately upon procedure completion (at the time of needle removal) and fluid extraction.
Incidence of Cough
Immediately upon procedure completion (at the time of needle removal) and fluid extraction.
Other Outcomes (1)
Reason for Procedure Termination
Immediately upon procedure completion (at the time of needle removal) and fluid extraction.
Study Arms (2)
Active Aspiration
EXPERIMENTALFor the Active Aspiration Group (n=30), fluid was actively aspirated using a syringe and expelled into a collection bag via a 3-way stopcock.
Passive Aspiration
EXPERIMENTALIn the passive Aspiration Group (n=30), after initial aspiration to confirm needle placement, the syringe was removed, and fluid was allowed to drain passively via gravity into the collection bag.
Interventions
For the Active Manual Syringe Aspiration, the operator manually withdraws pleural fluid using a syringe attached to a 3-way stopcock and transfusion set. The fluid is then expelled into a collection bag.
In Passive Gravity Drainage, after confirming proper needle placement with initial aspiration, the syringe is detached, and pleural fluid is allowed to drain passively by gravity through the transfusion set into a collection bag.
Eligibility Criteria
You may qualify if:
- Patients of either gender.
- Aged above 18 years.
- With symptomatic large pleural effusion (either exudative or transudative).
- Requiring therapeutic pleurocentesis.
- Modified Medical Research Council (mMRC) dyspnea scale grade 3-4.
You may not qualify if:
- Uncorrected bleeding diathesis.
- Chest wall cellulitis at the intended site of puncture.
- Uncooperative patients.
- Loculated pleural effusion.
- Traumatic hemothorax.
- Empyema thoracis.
- Hydropneumothorax.
- Patients who refused to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sheikh Zayed Hospital
Lahore, Punjab Province, 54470, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Dr. Talha Mahmud
Study Record Dates
First Submitted
September 7, 2025
First Posted
September 22, 2025
Study Start
March 1, 2020
Primary Completion
March 1, 2022
Study Completion
March 1, 2022
Last Updated
September 22, 2025
Record last verified: 2025-09